Hyperactivity
Posted by admin on Monday Feb 6, 2012 Under ADHD
Aarkstore Enterprise-Attention Deficit Hyperactivity Disorder (Adhd) Therapeutics
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics – Pipeline Assessment and Market Forecasts to 2017
The industry analysis specialist, has released its new report, “Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global ADHD market. The report identifies the key trends shaping and driving the global ADHD market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global ADHD sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData estimated the ADHD market to be worth $3.82 billion in 2009 and it is forecast to remain stable with a very low growth of a CAGR of 0.2% annually for the next seven years, to reach $3.88 billion by 2017. This modest growth can be primarily attributed to population growth and increased prescription rates. However, a low treatment seeking rate, low diagnosis rate, combined with the availability of alternate options such as generics, behavioral and psychological therapies, diet changes, as well as the unknown cause of the disease, continue to pose significant challenges for prospective market entrants.
Scope
The report provides information on the key drivers and challenges of the ADHD market. Its scope includes:
– Annualized global ADHD market revenues data from 2001 to 2009, forecast for eight years to 2017.
– Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as serotonin reuptake inhibitors, neuronal nicotine receptors agonists, dopamine reuptake inhibitors, AMPA type glutamate receptors.
– Analysis of the current and future competition in the global ADHD market. Key market players covered are Sceile Pharma, AstraZeneca, Supernus Pharma, Cortex pharma.
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the ADHD therapeutics market.
For more information, please contact :
http://www.aarkstore.com/reports/Attention-Deficit-Hyperactivity-Disorder-ADHD-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2017-40555.html
Related Reports
Disease and Therapy Review: Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q1, 2011
Attention Deficit Hyperactivity Disorder (ADHD) – Pipeline Review, Q1 2011
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q4, 2010
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Attention Deficit Hyperactivity Disorder (ADHD) – Pipeline Review, Q4 2010
|
|
Boy with a blue tongue Photo Mugs MODEL RELEASED. Boy with a blue tongue, stained byfood colouring from a lollipop. He is six yearsold….. |
|
|
Boy eatng chocolate cake Photo Mugs MODEL RELEASED. Boy eating chocolate cake. Sweet foods such as cake contain high amounts ofsugar and fat and eating too much can lead tochildhood obesity. These foods may also containadditives, colourings and preservatives which maystimulate hyperactive behaviour in children. Sweetfoods are also a major cause of tooth decay….. |
|
|
Ritalin molecule Photo Mugs Ritalin. Computer graphic of a molecule of the stimulant drug methylphenidate (C14. H19. N. O2), marketed as Ritalin. The atoms (tubes) of the molecule are colour-coded carbon (yellow), oxygen (red), hydrogen (white) and nitrogen (blue). It is a stimulant of the central nervous system, and is used to treat attention deficit disorder. This is a psychiatric disorder where young children become hyper… |
|
|
Canine Lullabies: Heartbeat Music Therapy, Vols. 1-2 $16.95 Canine Lullabies Combo CD Vol. 2 is just as amazing as Vol. 1, only now it includes all 18 songs from the Musical Therapy Combo CD: London Bridge, Rock-A-Bye Baby, Are You Sleeping?, Lullaby and Good Night, Twinkle, Twinkle, Little Star, Row, Row, Row Your Boat, Mary Had a Little Lamb, Hush Little Baby, and Old McDonald (Had a Farm), This Ole Man, Ten Little Indians, Skip To My Lou, My Bonnie (Lie… |
|
|
Focus On Adhd: Music for Attention Deficit Hyperactivity Disorder, Concentration and Study (Beta Binaural Beat Embedded) $8.99 … |
|
|
Magnificently Minded Volume #1 & 2 $0.99 In this two CD set, two ADD/ADHD experts collaborate to help you to see ADD/ADHD in a new light.CD #1 provides two educational and inspirational speeches by world reknowned Psychiatrist and ADD/ADHD Expert Dr. Edward Hallowell, with discussion and explanation by ADD/ADHD Psychiatrist and Expert, Dr. Kenny Handelman.Part 1 of this CD is the ADD Sililoquy, where Dr. Hallowell shares a first person a… |
|
|
Jumpin’ Johnny, GET BACK TO WORK! A Child’s Guide to ADHD/Hyperactivity 1994 VHS… |
|
|
Medical Management of Attention Deficit Hyperactivity Disorder Part I [VHS] $30.95 … |
|
|
Medical Management of Attention Deficit Hyperactivity Disorder: Part II [VHS] $35.95 … |
|
|
Investigative Reports : Attention Deficit Hyperactivity and the Drugs Used to Treat It $7.99 A look at how America’s love affair with prescription drugs has moved into the playpen.Today, 4 million children begin their school day by taking a small yellow pill, Ritalin, to control their hyperactivity. Since 1990, there has been a 700% increase in the use of the stimulant. And more than 2.5 million prescriptions for anti-depressants were written for pre-schoolers and adolescents. We look at … |
|
|
Hyperactive (Hardcover) $33.68 Each year, doctors diagnose an average of nine percent of children between the ages of five and seventeen with attention deficit hyperactivity disorder, or ADHD. One of the most common childhood disorders, it is also one of the most controversial?… |
|
|
Hyperactive (Paperback) $10.93 When Joey discovers he has the power of super speed, he must evade capture from an evil pharmaceutical company who wants to harness his power while surviving the perils of school life. |
|
|
An Alternative History of Hyperactivity (Hardcover) $39.62 Description not available. |
|
|
Helping Hyperactive Kids – a Sensory Integration Approach (Paperback) $12.19 Draws on sensory integration therapy practices to counsel parents and caregivers on a program that bases treatment on play, explaining how to help hyperactive children absorb, process, and respond to information in appropriate ways. Original. |
|
|
Understanding Attention Deficit Hyperactivity Disorder $13.86 Description not available. |
|
|
Philipp Gropper – Hyperactive Kid 3 * $20.43 Disc 0:No track list available |
|
|
Understanding Girls With Attention Deficit Hyperactivity Disorder $13.43 Description not available. |
|
|
Behavioral Neurobiology of Attention Deficit Hyperactivity Disorder and Its Treatment (Hardcover) $203.99 In this volume there is a strong emphasis on translational science, with preclinical approaches suggesting new directions for development of new treatments. Individual chapters describe how neuroimaging, neuroendocrine, genetic and behavioral studies … |
|
|
Scattered Minds $14.2 Description not available. |
|
|
Ritalin and Related Drugs (Hardcover) $29.71 Ritalin and related drugs are used primarily to treat children, teens, and adults with attention-deficit/hyperactivity disorder. ADHD is marked by hyperactivity, inattention, and impulsive behavior and affects five to eight percent of scho… |